Company Filing History:
Years Active: 2011-2013
Title: The Innovative Contributions of Allan Ma
Introduction
Allan Ma is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of immunology through his innovative research and development of chimeric antigens. With a total of 3 patents to his name, Ma's work has the potential to advance therapeutic strategies for immune responses.
Latest Patents
One of Allan Ma's latest patents focuses on chimeric antigens for eliciting an immune response. The patent discloses compositions and methods designed to provoke immune responses against antigens that the host typically recognizes as 'self' antigens. The immune response is enhanced by presenting the host immune system with a chimeric antigen that includes an immune response domain and a target binding domain. The target binding domain comprises a xenotypic antibody fragment, allowing antigen-presenting cells to uptake, process, and present the chimeric antigen. This process elicits both humoral and cellular immune responses, showcasing the innovative nature of Ma's work.
Career Highlights
Throughout his career, Allan Ma has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Paladin Labs Inc. and Akshaya Bio Inc. His experience in these organizations has contributed to his expertise in developing novel immunological therapies.
Collaborations
Allan Ma has collaborated with esteemed colleagues, including Rajan George and Lorne Tyrrell. These partnerships have likely enriched his research and expanded the impact of his innovations in the field.
Conclusion
Allan Ma's contributions to immunology through his patents and collaborations highlight his role as an influential inventor. His work on chimeric antigens represents a significant advancement in eliciting immune responses, paving the way for future therapeutic developments.